Lavipharm SA banner
L

Lavipharm SA
ATHEX:LAVI

Watchlist Manager
Lavipharm SA
ATHEX:LAVI
Watchlist
Price: 1.326 EUR -2.5% Market Closed
Market Cap: €223.7m

Balance Sheet

Balance Sheet Decomposition
Lavipharm SA

Balance Sheet
Lavipharm SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
26
19
18
16
18
6
13
8
13
11
10
8
4
2
2
2
2
2
2
2
2
18
8
6
Cash
0
0
0
1
1
1
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
8
6
Cash Equivalents
26
19
17
15
17
6
13
8
12
10
10
8
4
2
2
2
2
2
2
2
2
18
0
0
Short-Term Investments
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
119
134
151
141
73
81
82
76
93
82
44
19
21
14
15
14
12
12
13
13
15
17
22
18
Accounts Receivables
84
91
105
94
43
34
82
76
93
0
0
9
0
0
0
0
0
0
0
0
0
0
19
16
Other Receivables
35
43
47
47
30
47
0
0
0
0
0
9
0
0
0
0
0
0
0
0
0
0
3
3
Inventory
27
28
23
23
19
25
18
19
16
12
8
7
5
4
4
6
5
5
6
8
9
10
15
19
Other Current Assets
3
3
3
3
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
1
2
Total Current Assets
176
185
195
183
109
112
114
103
122
106
62
37
30
20
21
21
20
19
21
23
26
46
46
45
PP&E Net
18
19
17
17
37
36
34
33
32
31
28
26
23
23
22
19
15
15
16
16
17
17
20
21
PP&E Gross
18
19
17
17
37
36
34
33
32
31
28
26
0
0
0
0
0
0
0
0
0
0
20
21
Accumulated Depreciation
21
24
25
27
19
20
22
22
23
25
26
26
0
0
0
0
0
0
0
0
0
0
21
21
Intangible Assets
4
22
27
32
46
47
50
47
45
45
44
44
41
31
30
3
3
3
3
3
4
46
45
50
Goodwill
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
6
7
7
7
1
1
0
1
1
1
1
1
1
0
0
Long-Term Investments
48
47
48
48
0
1
2
2
2
2
1
2
2
2
2
1
2
2
2
2
2
2
4
3
Other Long-Term Assets
12
6
5
3
2
0
3
5
6
3
4
4
5
7
6
3
4
2
6
4
3
2
1
7
Other Assets
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
259
N/A
279
+8%
293
+5%
285
-2%
195
-32%
197
+1%
203
+3%
190
-6%
207
+9%
192
-7%
146
-24%
120
-17%
108
-10%
84
-22%
82
-2%
48
-42%
45
-7%
42
-6%
49
+18%
50
+2%
53
+4%
114
+116%
115
+1%
125
+9%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
0
1
1
2
1
28
27
25
21
18
13
15
15
19
23
27
27
Accrued Liabilities
1
2
2
4
2
2
0
1
7
7
5
7
0
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
23
29
27
31
29
32
0
27
28
23
13
8
0
0
0
0
0
1
1
1
1
0
3
5
Current Portion of Long-Term Debt
67
60
88
96
86
87
43
65
49
38
36
40
39
52
61
21
1
1
1
2
2
22
6
7
Other Current Liabilities
53
62
66
46
54
27
61
27
19
17
16
16
1
0
0
0
0
0
0
0
0
1
0
1
Total Current Liabilities
144
152
184
176
171
147
104
121
105
86
72
71
67
79
87
42
19
15
17
19
23
46
36
39
Long-Term Debt
0
26
16
12
7
34
59
43
72
82
65
52
53
48
51
57
40
38
37
35
33
15
24
22
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
4
3
2
0
1
1
1
1
1
12
15
17
13
23
29
25
0
0
0
0
0
0
0
0
Other Liabilities
7
11
4
5
9
5
3
7
8
7
5
4
4
6
8
6
5
8
9
8
7
13
13
11
Total Liabilities
156
N/A
192
+23%
206
+7%
193
-6%
187
-3%
188
+0%
167
-11%
172
+3%
185
+8%
163
-12%
128
-21%
111
-14%
110
-1%
110
+0%
118
+8%
80
-32%
65
-19%
61
-5%
64
+4%
62
-3%
63
+1%
74
+18%
72
-2%
73
+1%
Equity
Common Stock
35
39
39
39
39
39
51
51
51
51
51
51
51
51
51
51
51
51
51
51
51
50
50
51
Retained Earnings
6
9
10
5
91
90
100
117
114
106
116
124
137
159
166
160
155
155
150
147
145
17
15
5
Additional Paid In Capital
63
60
60
60
60
60
84
84
84
84
84
84
84
84
84
84
84
84
84
84
84
7
7
7
Treasury Stock
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
2
0
0
0
1
1
0
1
0
1
2
1
0
0
6
7
0
0
0
0
0
0
0
0
Total Equity
103
N/A
88
-15%
87
-1%
92
+6%
8
-92%
9
+19%
36
+302%
18
-50%
22
+21%
29
+34%
18
-39%
10
-44%
2
N/A
26
-1 633%
36
-38%
32
+11%
20
+37%
20
+2%
14
+26%
12
+19%
10
+15%
40
N/A
43
+6%
53
+24%
Total Liabilities & Equity
259
N/A
279
+8%
293
+5%
285
-2%
195
-32%
197
+1%
203
+3%
190
-6%
207
+9%
192
-7%
146
-24%
120
-17%
108
-10%
84
-22%
82
-2%
48
-42%
45
-7%
42
-6%
49
+18%
50
+2%
53
+4%
114
+116%
115
+1%
125
+9%
Shares Outstanding
Common Shares Outstanding
42
42
42
42
42
42
51
51
51
51
51
51
51
51
51
18
18
18
18
18
18
168
168
169
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett